MedTrace Logo

Patient Reported Outcomes With LASIK: PROWL-2

NCT01655420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-02-08

No results posted yet for this study

Summary

This study evaluates a questionaire designed to measure satisfaction and ophthalmic-related quality of life (QoL) of 300 civilian participants prior to and three months following state-of-the-art laser in situ keratomileusis (LASIK).

Conditions

  • Laser in Situ Keratomileusis

Interventions

PROCEDURE

LASIK

Laser eye surgery

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Food and Drug Administration (FDA)

    lead FED

Eligibility

Min Age
21 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655420 on ClinicalTrials.gov